Label: PRADA REVEAL SKIN OPTIMIZING FOUNDATION BROAD SPECTRUM SPF 17 SUNSCREEN- ensulizole liquid

  • NDC Code(s): 49967-380-01, 49967-380-02, 49967-380-03
  • Packager: L'Oreal USA Products Inc
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated December 18, 2023

If you are a consumer or patient please visit this version.

  • Active ingredient

    Ensulizole 2.7%

  • Purpose

    Sunscreen

  • Uses

    • helps prevent sunburn

    • if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun

  • Warnings

    For external use only

  • Flammable until dry.

    Do not use near fire, flame or heat.

  • Do not use

    on damaged or broken skin

  • When using this product

    keep out of eyes. Rinse with water to remove.

  • Stop use and ask a doctor if

    rash occurs

  • Keep out of reach of children.

    If swallowed, get medical help or contact a Poison Control Center right away.

  • Directions

    For sunscreen use:

    ● shake well before use

    ● apply liberally 15 minutes before sun exposure

    ● reapply at least every 2 hours

    ● use a water resistant sunscreen if swimming or sweating

    Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:

    ● limit time in the sun, especially from 10 a.m. – 2 p.m.

    ● wear long-sleeved shirts, pants, hats, and sunglasses

    ● children under 6 months of age: Ask a doctor

  • Other information

    protect the product in this container from excessive heat and direct sun

  • Inactive ingredients

    dimethicone, water, isododecane, alcohol denat., trimethylsiloxysilicate, propylene glycol, PEG/PPG-18/18 dimethicone, glycerin, niacinamide, silica, synthetic fluorphlogopite, polysilicone-11, hydroxyethylpiperazine ethane sulfonic acid, sodium chloride, phenoxyethanol, PEG-10 dimethicone, silica silylate, sodium hydroxide, disodium stearoyl glutamate, tocopherol, fragrance, alpha-glucan oligosaccharide, aluminum hydroxide, polymnia sonchifolia root juice, limonene, maltodextrin, alpha-isomethyl ionone, lactobacillus, geraniol, citronellol, citric acid; may contain: titanium dioxide, iron oxides

  • PRINCIPAL DISPLAY PANEL

    image of a carton

    image of a carton
  • INGREDIENTS AND APPEARANCE
    PRADA REVEAL SKIN OPTIMIZING FOUNDATION BROAD SPECTRUM SPF 17 SUNSCREEN 
    ensulizole liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:49967-380
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ENSULIZOLE (UNII: 9YQ9DI1W42) (ENSULIZOLE - UNII:9YQ9DI1W42) ENSULIZOLE27 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    DIMETHICONE (UNII: 92RU3N3Y1O)  
    WATER (UNII: 059QF0KO0R)  
    ISODODECANE (UNII: A8289P68Y2)  
    ALCOHOL (UNII: 3K9958V90M)  
    TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    PEG/PPG-18/18 DIMETHICONE (UNII: 9H0AO7T794)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    NIACINAMIDE (UNII: 25X51I8RD4)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    DIMETHICONE/VINYL DIMETHICONE CROSSPOLYMER (SOFT PARTICLE) (UNII: 9E4CO0W6C5)  
    HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID (UNII: RWW266YE9I)  
    SODIUM CHLORIDE (UNII: 451W47IQ8X)  
    PHENOXYETHANOL (UNII: HIE492ZZ3T)  
    PEG-10 DIMETHICONE (600 CST) (UNII: 8PR7V1SVM0)  
    SODIUM HYDROXIDE (UNII: 55X04QC32I)  
    DISODIUM STEAROYL GLUTAMATE (UNII: 45ASM2L11M)  
    TOCOPHEROL (UNII: R0ZB2556P8)  
    .ALPHA.-GLUCAN OLIGOSACCHARIDE (UNII: S95658MI3W)  
    ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)  
    LIMONENE, (+)- (UNII: GFD7C86Q1W)  
    MALTODEXTRIN (UNII: 7CVR7L4A2D)  
    ISOMETHYL-.ALPHA.-IONONE (UNII: 9XP4LC555B)  
    LACTOBACILLUS ACIDOPHILUS BCMC 12130 (UNII: MVC2243UZX)  
    GERANIOL (UNII: L837108USY)  
    CITRONELLOL ACETATE, (S)- (UNII: 78RZL4H51H)  
    CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    FERRIC OXIDE RED (UNII: 1K09F3G675)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:49967-380-011 in 1 CARTON06/01/2023
    130 mL in 1 BOTTLE; Type 0: Not a Combination Product
    2NDC:49967-380-023 mL in 1 PACKAGE; Type 0: Not a Combination Product06/01/2023
    3NDC:49967-380-031 mL in 1 PACKET; Type 0: Not a Combination Product06/01/2023
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM02006/01/2023
    Labeler - L'Oreal USA Products Inc (002136794)
    Establishment
    NameAddressID/FEIBusiness Operations
    SICOS ET CIE276993581manufacture(49967-380)
    Establishment
    NameAddressID/FEIBusiness Operations
    BPS 60272259304pack(49967-380)
    Establishment
    NameAddressID/FEIBusiness Operations
    Socoplan276221405pack(49967-380)